Article info
PDFClinical and epidemiological research
Extended report
A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout
- Correspondence to Professor Lisa K Stamp, Department of Medicine, University of Otago, Christchurch, P.O. Box 4345, Christchurch 8014, New Zealand; lisa.stamp{at}cdhb.health.nz
Citation
A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout
Publication history
- Received November 24, 2016
- Revised February 21, 2017
- Accepted February 22, 2017
- First published March 17, 2017.
Online issue publication
August 10, 2017
Article Versions
- Previous version (17 March 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/